NuCana plc: NuCana Announces Update for Phase 3 Biliary Tract Cancer Study
Independent Data Monitoring Committee Recommended Study be Discontinued Following Futility Assessment Conducted at First Interim Analysis NUC-3373 Continues Rapid Development with Multiple Data Readouts
Source: finanznachrichten.de